Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer care for Ukrainian refugees during the first 6 weeks of 2022 Russian invasion - An experience of a cancer reference centre in Poland.
Püsküllüoğlu M, Grela-Wojewoda A, Szczubiałka G, Zemełka T, Lompart J, Sałek-Zań A, Kopciński T, Pasieka E, Adamczyk A, Mucha-Małecka A, Kłęk S, Ryś J, Ziobro M. Püsküllüoğlu M, et al. Eur J Cancer. 2023 Jan;178:234-242. doi: 10.1016/j.ejca.2022.10.005. Epub 2022 Oct 20. Eur J Cancer. 2023. PMID: 36371305 Free article.
Adjuvant combined therapy with trastuzumab in patients with HER2‑ positive breast cancer and cardiac alterations: implications for optimal cardio‑oncology care.
Grela-Wojewoda A, Niemiec J, Sas-Korczyńska B, Zemełka T, Puskulluoglu M, Wysocki WM, Wojewoda T, Pacholczak-Madej R, Adamczyk A, Mucha-Małecka A, Ziobro M, Konduracka E. Grela-Wojewoda A, et al. Among authors: puskulluoglu m. Pol Arch Intern Med. 2022 Apr 28;132(4):16204. doi: 10.20452/pamw.16204. Epub 2022 Jan 28. Pol Arch Intern Med. 2022. PMID: 35089680 Free article.
Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population.
Grela-Wojewoda A, Püsküllüoğlu M, Sas-Korczyńska B, Zemełka T, Pacholczak-Madej R, Wysocki WM, Wojewoda T, Adamczyk A, Lompart J, Korman M, Mucha-Małecka A, Ziobro M, Konduracka E. Grela-Wojewoda A, et al. Among authors: puskulluoglu m. Cancers (Basel). 2022 Jul 10;14(14):3353. doi: 10.3390/cancers14143353. Cancers (Basel). 2022. PMID: 35884413 Free PMC article.
Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience.
Pacholczak-Madej R, Grela-Wojewoda A, Puskulluoglu M, Lompart J, Las-Jankowska M, Krawczak K, Wrona E, Zaręba L, Żubrowska J, Walocha J, Bazan-Socha S, Ziobro M. Pacholczak-Madej R, et al. Among authors: puskulluoglu m. Biomedicines. 2022 Oct 10;10(10):2528. doi: 10.3390/biomedicines10102528. Biomedicines. 2022. PMID: 36289790 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 35048643
Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature.
Streb J, Püsküllüoğlu M, Glanowska I, Ochenduszko S, Konopka K, Łupkowski R, Michalowska-Kaczmarczyk A, Bochenek-Cibor J, Majka M, Krzemieniecki K. Streb J, et al. Among authors: puskulluoglu m. Oncol Lett. 2015 Dec;10(6):3749-3755. doi: 10.3892/ol.2015.3800. Epub 2015 Oct 12. Oncol Lett. 2015. PMID: 26788202 Free PMC article.
43 results